2025 U.S. Generic & Biosimilar Medicines Savings Report
Generics comprised 90% of all prescriptions filled, but only 12% of prescription spending. Brand drugs made up only 10% of prescriptions filled but added up to 88% of the total drug spend.
The Generics Industry Wants a Healthy America
Low-cost generics and biosimilars positively impact the health of American patients. Plus, over the past decade, widespread adoption has saved the U.S. healthcare system $3.1 trillion. But this success story is in jeopardy.
AAM White Paper: Hatch-Waxman Turns 40
“Since the introduction of this law, we have all seen incredible savings. But even as we celebrate the success of forty years of Hatch-Waxman, those savings, the increased patient access, and a model of generic adoption that leads the world, are at risk.” — David Gaugh, Interim President & CEO, AAM.
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?
Avalere analysis finds Part D prescription drug plans continue to increase patient copays for generics by moving them to higher tiers.
Quick Links:
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
